The governing board of the California Institute for Regenerative Medicine announced Wednesday that it was appointing C Randal Mills as the stem cell agencys new president and chief executive officer Mills the former chief executive of Columbia Mdbased Osiris Therapeutics Inc was among seven finalists for the position according to an agency news release During his year tenure at Osiris Mills oversaw the first commercialization of a stem cell drug Prochymal which is used to treat acute graftversushost disease in children The deadly disease is a complication of bone marrow transplants I am so incredibly honored to be selected to be the next leader of CIRM Mills said Wednesday Above not just any other state but above every other country California is going to take the lead in regenerative medicine The promise I make to you the board and the people of California is that were going to work relentlessly for the benefit of the patients and the people of California he said Mills who earned a bachelors degree in microbiology and cell science and a doctorate in drug development from the University of Florida has been a member of CIRMs grant review board for the last five years Jonathan Thomas who heads the agencys governing board  the Independent Citizens Oversight Committee  said Mills was selected in part for his experience in raising money for clinical research and working with regulatory authorities The board also wanted a leader who would take stock of our wonderful programs come and evaluate what were doing right and what could benefit from adjustments Thomas told reporters at a news conference Hell bring a fresh set of eyes and will help work with our staff on our directions going forward We could not be happier Thomas said Mills will replace Alan Trounson who stepped down after six years to spend more time with his family in Australia the agency said Prior to Osiris Mills held several executive titles at RTI Biolgics Inc and was a founding member of that companys predecessor the University of Florida Tissue Bank He has also served as a voting member of the National Institutes of Health and AIDS Research Advisory Council CIRM was established in  with the passage of Proposition  the California Stem Cell Research and Cures Act